Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs74712819 | chr16:56461773 | G/A | 0.000204 | 177 | 25.17 | 26.97 | 36.37 | KM Plot |
PCPG | rs74742778 | chr13:114155356 | A/T | 4.65E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs74748005 | chr2:118697271 | A/G | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs74772751 | chr10:131542443 | C/G | 0.000116 | 174 | 25.4 | 30.18 | 10.3 | KM Plot |
PCPG | rs74841729 | chr20:6006043 | A/T | 0 | 178 | 25.47 | 23.53 | 2.93 | KM Plot |
PCPG | rs74871253 | chr7:1131141 | C/G | 1.13E-7 | 175 | 25.7 | 23.57 | 19.87 | KM Plot |
PCPG | rs74887741 | chr7:1110658 | G/T | 0.000259 | 174 | 25.7 | 24.95 | 49.58 | KM Plot |
PCPG | rs74908758 | chr16:71704511 | ATAGT/A | 9.19E-6 | 174 | 24.47 | 31.48 | 14.5 | KM Plot |
PCPG | rs74936050 | chr7:36154778 | G/A | 0.000433 | 178 | 25.77 | 24.5 | 14.37 | KM Plot |
PCPG | rs74942326 | chr8:140986284 | T/C | 1.11E-16 | 174 | 25.4 | 30.65 | 3.17 | KM Plot |
PCPG | rs74947370 | chr16:1976625 | A/T | 1.22E-5 | 174 | 25.77 | 23.37 | 13.23 | KM Plot |
PCPG | rs74947872 | chr2:242535065 | G/A | 4.16E-5 | 177 | 25.87 | 27.27 | 20.2 | KM Plot |
PCPG | rs74957414 | chr17:1422821 | C/T | 1.37E-5 | 176 | 24.7 | 25.87 | 13.02 | KM Plot |
PCPG | rs74959868 | chr7:158686963 | T/C | 0 | 177 | 25.53 | 20.37 | 3.17 | KM Plot |
PCPG | rs74960156 | chr19:58147989 | A/C | 2.64E-11 | 172 | 25.97 | 21.98 | 10.3 | KM Plot |